Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT05150691What this trial is testingA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsWho this might be right forHER2-positive Advanced Solid Tumor DualityBio Inc. 796
Not applicableStudy completedNCT00428220What this trial is testingA Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.Who this might be right forMetastatic Breast CancerAdvanced Breast CancerMetastatic Castration Resistant Prostate Cancer+9 more Pfizer 223
Early research (Phase 1)Study completedNCT04430842What this trial is testingDose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SWho this might be right forAstrocytomaBrain CancerBrain Metastases+20 more Quadriga Biosciences, Inc. 15
Large-scale testing (Phase 3)Study completedNCT00324727What this trial is testingHepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to MelanomaWho this might be right forIntraocular MelanomaMelanoma (Skin)Metastatic Cancer Delcath Systems Inc. 93
Large-scale testing (Phase 3)Ended earlyNCT01189227What this trial is testingCombination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By SurgeryWho this might be right forColorectal CancerMetastatic Cancer NSABP Foundation Inc 9
Early research (Phase 1)Study completedNCT03849469What this trial is testingXmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsWho this might be right forMelanomaCervical CarcinomaPancreatic Carcinoma+20 more Xencor, Inc. 78
Very early researchStudy completedNCT03888859What this trial is testingET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular CarcinomaWho this might be right forHepatocellular CarcinomaLiver CancerLiver Neoplasms+1 more First Affiliated Hospital Xi'an Jiaotong University 12
Testing effectiveness (Phase 2)Looking for participantsNCT05040360What this trial is testingTesting the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine TumorsWho this might be right forMetastatic Malignant Neoplasm in the LiverPancreatic Neuroendocrine TumorStage I Pancreatic Neuroendocrine Tumor AJCC v8+2 more SWOG Cancer Research Network 141
Testing effectiveness (Phase 2)Study completedNCT00006050What this trial is testingCombination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the LiverWho this might be right forColorectal CancerMetastatic Cancer UNICANCER
Not applicableStudy completedNCT00392366What this trial is testingLaser Interstitial Thermal Therapy Under "Real Time" MRI Guidance for "Minimal Invasive" Treatment of Liver MetastasisWho this might be right forCarcinoma, HepatocellularLiver NeoplasmsDigestive System Neoplasms BioTex, Inc. 25
Not applicableUnknownNCT03881501What this trial is testingEvaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Non-resectable Huazhong University of Science and Technology 2
Testing effectiveness (Phase 2)Study completedNCT00866944What this trial is testingStudy of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver MetastasesWho this might be right forLiver MetastasesColorectal Cancer Amgen Research (Munich) GmbH 35
Testing effectiveness (Phase 2)Looking for participantsNCT06875128What this trial is testingEvaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant DiseaseWho this might be right forMetastatic Breast Cancer in the Liver Delcath Systems Inc. 90
Testing effectiveness (Phase 2)Study completedNCT04401800What this trial is testingPreliminary Antitumor Activity, Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular CarcinomaWho this might be right forHepatocellular CarcinomaUnresectable Hepatocellular CarcinomaMetastatic Hepatocellular Carcinoma BeiGene 64
Testing effectiveness (Phase 2)WithdrawnNCT03069950What this trial is testingStudy of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the LiverWho this might be right forColorectal Adenocarcinoma Metastatic to the Liver Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07179900What this trial is testingRadiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Hebei Medical University Fourth Hospital 60
Not applicableStudy completedNCT02761356What this trial is testingThe Added Value of Hybrid Functional Anatomical Imaging PET-CT and SPECT-CT in Patients Treated With Y-90 SIRT for Liver MalignanciesWho this might be right forPrimary Liver Tumor, Metastatic Liver Tel-Aviv Sourasky Medical Center 50
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT00654160What this trial is testingIrinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerWho this might be right forAnal CancerCarcinoma of the AppendixColorectal Cancer+9 more Mayo Clinic 7